Head of GSK in China is replaced as details of fraud scandal emerge

GSK will resume paying doctors to promote its drugs after policy U turn

“…That move came amid a major bribery investigation in China, which resulted in a record fine, and was an attempt to improve the company’s reputation 23. GSK had hoped that other companies would follow suit, but this did not happen, placing it at a competitive disadvantage.…”